Advertisement

News & Opinion

» evolution and opinion

Covering the life sciences inside and out

Most Recent

image: Opinion: The Precarious Earth

Opinion: The Precarious Earth

By | June 18, 2012

People are currently driving the planet on a crash course with global stability. Something must be done.

39 Comments

image: Opinion: What’s Wrong with COI?

Opinion: What’s Wrong with COI?

By | June 12, 2012

Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.

0 Comments

image: Opinion: Justice Delayed, Health Denied

Opinion: Justice Delayed, Health Denied

By | June 4, 2012

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

12 Comments

image: Opinion: Pressured to Commercialize

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: Opinion: Saving Species through Economics

Opinion: Saving Species through Economics

By | May 21, 2012

Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.

4 Comments

image: Revenge of the Weeds

Revenge of the Weeds

By | May 20, 2012

Plant pests are evolving to outsmart common herbicides, costing farmers crops and money.

33 Comments

image: Live Slow, Die Old

Live Slow, Die Old

By | May 17, 2012

Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.

13 Comments

image: How Prawns Lure Prey

How Prawns Lure Prey

By | May 15, 2012

Orange-loving Trinidad guppies are curiously attracted to orange spots on prawn pincers, which may make it easier for the predators to snatch them up.

1 Comment

image: Behavior Brief

Behavior Brief

By | May 15, 2012

A round-up of recent discoveries in behavior research

5 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies